Owing to the threat of organophosphate exposures, not only to pesticides but also to nerve agents, it is very important to know the whole process of organophosphates-inhibited acetylcholinesterase (AChE, EC 3.1.1.7) reactivation. Although current antidotes against organophosphorus intoxications consist also of prophylactics, AChE reactivators are still needed especially in the case of intoxications with high doses of organophosphates, for which prophylactic treatment is not effective. For this reason, new AChE reactivators are still being developed. Our work summarizes accurately the whole reactivation process, and offers some help for scientists who are interested in the area of AChE reactivation.
INTRODUCTION
Acetylcholinesterase (AChE, EC 3.1.1.7) is a crucial enzyme in the human body . It is affiliated with Alzheimer´s and Parkinson´s diseases and with many other degenerative disorders. AChE is the key enzyme that is targeted by organophosphate chemical warfare agents. AChE catalyzes the hydrolysis " Kamil Kuča, Department of Toxicology, School of Military Health Sciences, Třebešská 1575, University of Defence, 50001 Hradec Králové, Czech Republic # kucakam@pmfhk.cz of the neurotransmitter acetylcholine and terminates the impulse transmission at cholinergic synapses. Organophosphates known as the nerve agents -the chemical compounds with most military significance -are irreversible inhibitors of AChE. They are extremely toxic. The inhibition of AChE by organophosporus compounds could result in severe intoxication and death of the exposed individual. These compounds block the active site of the enzyme by covalent bond to the serine hydroxygroup oxygen. The complex of AChE and organophosphate can be reversed by introducing an AChE reactivator (called "oxime") into the system. Dissociated oximes were shown to be able to restore organophosphate-inhibited AChE and greatly attenuate the toxicity of many highly toxic organophosphates. Therefore, these compounds are known as reactivators of phosphorylated AChE. Reactivation of organophosphate-inhibited AChE by oximes is the primary reason for their effectiveness in the treatment of organophosphate, especially nerve agents poisoning. That is why oxime reactivators are very important therapeutics (Bajgar 2004a) . The objective of this review is a description of the kinetics and thermodynamics of the reactivation process and the different factors on which it depends.
ACETYLCHOLINESTERASE
AChE is a serine hydrolase that belongs to the esterases family within the higher eukaryotes. This family acts on different types of carboxylic esters. The biological role of AChE is the termination of impulse transmissions at cholinergic synapses within the nervous system by rapid hydrolysis of the neurotransmitter acetylcholine (Schumacher et al. 1986 ). The monomer of AChE with a molecular weight around 60000 is an ellipsoidal molecule, the size of which is approximately 45 × 60 × 65 angstroms, consisting of a 12 stranded central mixed beta sheet surrounded by 14 alpha helices (Sussman et al. 1991) . Each monomer contains one catalytic center composed of two compartments: the esteratic subsite containing the catalytic triad and the anionic subsite that accommodates the positive quaternary compartment of acetylcholine. The esteratic subsite contains the catalytic machinery of the enzyme: a catalytic triad of Ser 200, His 440, and Glu 327. The anionic subsite is defined by Trp 84, Phe 330, and Phe 331. Its role is to orient the charged part of the substrate that enters the active center. This role is the main function of the Trp residue (Sussman et al. 1991) . The recent rendition of the x-ray structure for AChE places the active catalytic site deep within a gorge-like fold of the protein. The aromatic gorge in the protein is approximately 20 angstroms deep and penetrates halfway into the enzyme. The active site lies at the base of this gorge only 4 angstroms above the base, leading some to label this the 'active gorge'. The 'aromatic' gorge is a more appropriate term, though, because 40% of its lining is composed of 14 aromatic residua located in the gorge which is highly conserved from different species of AChE (Harel et al. 1993) . The high aromatic content of the walls and floor may explain why studies have proposed hydrophobic and anionic binding sites independent of the active site. Only a few acidic residues are present within the gorge. The aromatic residues clearly play an important role in the stabilization of the complex. Electrostatic as well as hydrophobic effects are of importance here (Berman and Leonard 1990) . The electrostatic potential map of AChE suggests that this enzyme, possibly like other enzymes with charged substrates, steers its substrate toward its gorge and into the active site. The second anionic site of AChE, the so-called 'peripheral' anionic site is located at the active center gorge entry, encompasses overlapping binding sites for different activators and inhibitors. The peripheral anionic site consists of the residues Asp 74 and Trp 286 as a common core. Binding of ligands to these residues may be the key to the allosteric modulation of AChE catalytic activity (Bourne et al. 2003) .
TOXIC PHOSPHORUS ESTERS AND ACHE
The organophosporus compounds have drawn the interest of biochemists, physiologists, agriculturists and especially military chemists: all highly toxic organophosphorus chemical warfare agents (called nerve agents) are strong inhibitors of AChE. As mentioned above, these compounds irreversibly bind to AChE in the place of its catalytic center, causing the phosphorylation of the enzyme and subsequent inhibition of its activity. The normal function of AChE is to hydrolyse the neurotransmitter acetylcholine (ACh), which is released on the neural junction. Inhibition of the enzyme results in the accumulation of excessive concentrations of ACh at neural receptors. This accumulation at the endings of motor nerves to voluntary muscles and in some autonomic ganglia, results in nicotinic signs and symptoms, and its accumulation in the brain and spinal cord results in characteristic central nervous system symptoms (Bajgar 2004a , Bajgar 2004b .
INTERACTION OF ORGANOPHOSPHATES WITH ACHE
AChE reacts with organophosphorus compounds having the general structure I, II and III.
In many organophosphates of this type, R 1 and R 2 are an alkyl, dialkylaminoalkylthio or dialkylamido group, and X a halogen, cyanide, paranitrophenoxy, phenoxy, dialkylaminoalkylthio, or other similar group (Cabal 1992) . There are three principle reactions involved in enzyme-phosphate interaction: phosphorylation of the enzyme (1), reversal of inhibition (2), and aging (3).
Phosphorylation of the enzyme is characterized by the formation of a chemical bond between the phosphorus atom of organophosphate and the oxygen atom of the hydroxyl group of serine in the catalytic center of AChE. The reaction between organophosphates and AChE is analogous to the reaction between ACh and AChE, and can be represented as follows:
where E-OH represents a part of the esteratic site of AChE. The formation of acetylated enzyme by the binding of the acetyl group from Ach to a basic group of the esteratic site is considered as the ratedetermining step in this sequence of reaction. The acetylated enzyme is extremely unstable and has a half-life of a fraction of a millisecond. Phosphorylated AChE, unlike acetylated AChE, is extremely stable. Therefore, the inhibition of AChE by organophosphorus compounds, especially nerve agents, is called irreversible. Reversal of inhibition, i.e. reaction (2), proceeds at a very low rate, and for this reason, organophosphates are inhibitors and not substrates of AChE.
The chemical bond between the oxygen atom in enzyme and the phosphorus atom in organophosphate is very strong, the nucleophilicity of water molecule is too weak and dephosphorylation of enzyme, i.e., spontaneous reactivation of its activity is extremely slow. The reversal of the activity connected with dephosphorylation of AChE, can be accelerated by some strong nucleophilic agents. These compounds performed induced reactivation and are known as reactivators of the organophosphate-inhibited AChE. These agents are used as antidotes for the treatment of intoxications by toxic organophosphorus compounds.
Spontaneous reactivation is the combination of two parallel processes: dephosphorylation and aging. Aging is the formation of a fully irreversible form of the phosphorylated AChE in consequence of dealkylation of the O,O-dialkyl-phosphorylated or O-alkyl-phoshonylated enzyme. An aged enzyme cannot be reactivated by the reactivators of organophosphate-inhibited AChE. Aging is defined as dealkylation of the phosphoryl adduct to give a negatively charged adduct that is stabilized by interaction with the catalytic His 440 (Millard et al. 1999) .
Aging irreversibly prevents dephosphorylation and limits the amount of the enzyme that becomes reactivated.
PHOSPHORYLATION OF ACHE
The most important feature of many organophosphates is their ability to react with AChE at very low concentrations. This irreversible action may be described as a bimolecular reaction as follows:
It is possible to calculate the first-order rate constants (k obs ) by linear regression for any given inhibitor concentration using the formula: where v 0 and v i are enzyme activities in the absence and in the presence of the inhibitor (I) at the time t (Aldridge and Reiner 1969). The second-order inhibition rate constant (k i ) is calculated from the linear dependency of k obs from the inhibitor concentration: The reaction of organophosphate with AChE is progressive, i.e., the longer the inhibitor is in contact with the enzyme, the greater is the inhibition. The molar concentration of the inhibitor that gives 50% enzyme inhibition is called the I 50 . This parameter, and also the so-called pI 50 (the negative common logarithm of the I 50 ), is timedependent, and therefore, is not definitive unless the incubation time is known. The correct parameter to use is the bimolecular rate constant k i at a fixed temperature and pH. In fact these two terms are interconvertible, where t is the incubation time. The I 50 is far more popular in the literature because its units (i.e. molar concentration) are readily pictured and mentally manipulated, whereas the units of k i (i.e., L. 
KINETICS OF REACTIVATION OF ORGANOPHOSPHATE-INHIBITED ACHE
AChE that is inhibited by organophosphates can be reactivated by some nucleophilic compounds if it hasn't undergone a prior aging reaction. There is evidence that in the course of reactivation an intermediary complex between reactivator and inhibited enzyme is first formed. The kinetics of the reactivation process follows second-order kinetics and can be described schematically by the followed equation:
where EI is the phosphorylated and/or phosphonylated enzyme, R the reactivator, EIR the intermediary complex, P the reaction product, and E the enzyme. K R is the dissociation constant of complex EIR and k R the decomposition rate of this complex. The rate of reactivation at any moment depends on the oxime concentration and the amount of still not reactivated enzyme.
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A relation is usually derived for the calculation of these constants, which is identical with the equation characterizing the relation between the rate of the enzymatic reaction and the concentration of the substrate under the conditions of Michaelis kinetics. This equation in the following form permits the calculation of K R and k R and also of the The apparent rate constant k app can be calculated from the equation where v 0 and v i are the enzyme activities in the absence and in the presence of the inhibitor and v r is the enzyme activity in the presence of the reactivator.
Likewise as the inhibition effect can be expressed by I 50 value, the reactivation effect can also be qualified as a reactivator concentration able to restore 50% of inhibited enzyme in time t (R 50 ). This value (or other similar values, for example R 10 , R 90 ) are easily available from the percentage dependence of reactivated enzyme on reactivator concentration (Patočka 1972a) . The percentage of the reactivated enzyme can be estimated from the following equation:
Oxime reactivators Reactivators based on the oxime structure were discovered in the middle of the last century, when stronger nucleophilic reagents than water were synthesized. The most potent effect was produced when the reactivating oxime group was attached to a residue containing a quaternary nitrogen group, at a distance from the reactivating group similar to the distance between the anionic and esteratic site of AChE. Presumably, this conformation helps with the affinity of the reactivator molecule towards the active center of AChE. The first practically available oxime reactivator was prepared independently and almost simultaneously by Wilson and Ginsburg (1955) in the USA, and by Childs et al. (1955) in Great Britain.
It was 2-hydroxyiminomethyl-1-methylpyridinium iodide known as 2-PAM or pralidoxime (IV) (Fig. 1) . (1958) reported some new compounds, which were up to 22 times more potent than 2-PAM in reactivating organophosphate-inhibited AChE. These resembled two units of 2-PAM or 4-PAM (4-hydroxyiminomethyl-1-methylpyridinium iodide), joined at their quaternary nitrogen groups by a carbon chain, optimally 3 carbons long. These are for example 1,3-bis-(4-hydroxyiminomethylpyridinium)propane dibromide (TMB-4; trimedoxime, V) or 1,3-bis-(4-hydroxyiminomethylpyridinium) 2-oxapropane dichloride (LüH6; obidoxime; Toxogonin®, VI) (Fig. 1) . These compounds are known as bisquaternary pyridinium aldoximes. The mechanism of the reactivation process is shown in Reactivator-inhibitor complex
Fig. 2. Oxime reactivation of the organophosphate-inhibited AchE
Further, it was found that presence of a second aldoxime moiety in the reactivator molecule is not necessary for its reactivation potency. However, the presence of the second quaternary nitrogen increases the affinity of the reactivator toward the intact and inhibited AChE. Such a potent reactivator is bisquaternary monoaldoxime such as (1-(2-hydroxyiminomethylpyridinium)-3-(4-carbamoylpyridinium)-2-oxapropane dichloride) (HI-6, VII) (Figure 1) . Also newly synthesized reactivators -K027
(1-(4-hydroxyiminomethylpyridinium)-3-(4-carbamoylpyridinium) propane dibromide) and K048 (1-(4-hydroxyiminomethylpyridinium)-4-(4-carbamoylpyridinium) butane dibromide) are usually compounds of this type (Kuča et al. 2003a , Kuča et al 2003b .
Oxime reactivators of organophosphateinhibited AChE are believed to give rise to phosphorylated oximes that reinhibit the enzyme. It was demonstrated that phosphorylated oximes that were generated in situ were more potent inhibitors of AChE than the parent organophosphate (Leader et al. 1999) .
THE INFLUENCE OF OXIME REACTIVATORS ON INTACT ACHE
The affinity of oxime reactivators to the active center of AChE entails the action of these compounds as reversible competitive inhibitors of AChE. From the results with a homologous series of reactivators of the general structure α,ω-bis-(4-hydroxyiminomethylpyridinium)-polymethylene dihalogenide, it was found that during the binding of these compounds to the active center of AChE, both electrostatic forces and hydrophobic is implicit in the curve of dependence of percentage reactivation on reactivator concentration (Fig. 3) . This curve is bell-shaped (Kuča and Kassa 2003) . The first -increasing -part of the curve characterizes reactivation of the inhibited enzyme. On the other hand, the second -decreasing -part describes inhibition of the enzyme by the excess of the reactivator.
THE INFLUENCE OF pH ON KINETICS OF OXIME REACTIVATION
The regeneration of organophosphate-inhibited AChE by oximes is strongly dependent on pH. It is obvious, because only dissociated anion of oxime is able to break the bond between the organothosphorus inhibitor and the enzyme. It was deduced from the kinetic constants of reactivation obtained at different pH values that the decrease of k R values is dependent on pH. The intermediate complex EIR is more stable at higher pH therefore k R values increase when pH decreases (Patočka and Bielavský 1972b) .
The values of K R are dependent on pH, as the reactivation process is essentially ionic in nature, involving a protonated form of the inhibited enzyme and polar ion of the reactivator. The pH optimum of the reactivation process can be expressed as midway between pK a of the oxime group of reactivator and pK EI of the organophosphate-inhibited enzyme. The location of pH opt is in the physiological range of pH (Davies and Green 1956, Patočka and Bielavský 1972b) .
THE INFLUENCE OF TEMPERATURE ON S
The kinetic constant values of reactivation are commonly dependent on temperature, as are other enzyme-catalyzed reactions with higher temperature limitation of protein denaturation. It is possible to describe the dependence of the kinetic constant on reaction temperature by some thermodynamic functions but credible values for the reactivation process are very rare in the literature. The values of the standard free energy of binding (∆G 0 ) were calculated in experiments with the reactivation of sarin-inhibited AChE by α,ω-bis-(4-hydroxyiminomethylpyridinium)-2-trans-butene dibromide (Patočka 1972b ) from the equation
in a temperature interval from 5.2 to 40.8°C, where R is the universal gas constant and T is the absolute temperature. 
STRUCTURE -ACTIVITY RELATIONSHIPS
The discovery of the relationship between structure and the reactivation potency of AChE reactivators is not well documented. Some authors use computer-aided calculations for the prediction of new more potent AChE reactivators (Mager 1981 , Mager 1983 , Mager and Weber 2004 , Dohnal et al. 2003 . There are four important structural factors, which influence the affinity of the AChE reactivators toward inhibited AChE.
The presence of quaternary nitrogen in the molecule of reactivator is the first well-known factor. Moreover, a molecule with two quaternary nitrogens achieved higher affinity toward inhibited AChE compared to monoquaternary compounds (Kuča and Kassa 2003) .
The length of the connecting chain between both pyridinium rings by the bisquaternary pyridinium reactivator plays an important role in its potency (Patočka and Bielavský 1972a , Pang et al. 2003 , Kuča et al. 2003c ). Owing to this fact, it can be designed as the second structural factor. There is a dependence between the length of the linking chain and nerve agent used (Kuča et al. 2003c) . For example, the ideal length of connecting chain for reactivation of tabun, sarin or VX inhibited AChE is 3 or 4 methylene groups. On the other hand, methoxime (containing one methylene group) seems to be the most potent reactivator of cyclosarin inhibited AChE (Kassa and Cabal 1999; Kuča et al. 2003c) .
The presence of the oxime group in the structure of the reactivator is other substantial structural factor. Formerly, hydroxyiminoacetone, hydroxamic acids, geminal dioles, and ketoximes were used as potential nucleophilic agents for breaking the bond between inhibitor and enzyme (Heath 1961; Cabal et al 1998 , Kuca et al. 2004a ). The aldoxime group seems to be currently the most used, and therefore it is involved in all newly synthesized AChE reactivators.
The last important structural factor is also connected with the oxime group. It is the position of the oxime group at the quaternary pyridinium ring. It is generally known that position two and four are more suitable compared to position three. This fact is due to the difference in pK a between oximes in position two and four as against those in position three (Heath 1961) . The position of the oxime group is nerve agent dependent as well as the length of the connecting chain between the quaternary pyridinium rings. For example, cyclosarin inhibited AChE is best reactivated by reactivators with oxime in position two . On the other hand, reactivators with the oxime group at the pyridinium ring in position four are currently considered to be the most potent for reactivation of tabun-inhibited AChE (Cabal et al. 2004) .
CONCLUSION
Owing to the threat of organophosphate exposures, not only to pesticides but also nerve agents, it is very important to know the whole process of organophosphates-inhibited AChE reactivation. Although current antidotes against organophosphorus intoxications consist also of prophylactics, AChE reactivators are still needed, especially in the case of intoxications with high doses of organophosphates, for which prophylactic treatment is not effective. For this reason, new AChE reactivators are still being developed.
Our work summarizes accurately the reactivation process, and should be some help for scientists who are interested in the area of AChE reactivation. 
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